跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 908 条关于
“dolutegravir/lamivudine”
全部
908
临床试验
792
药物
77
机构
0
资讯
39
去年
Meta-Analysis Confirms Long-Term Effectiveness of Dolutegravir-Lamivudine HIV Treatment in Real-World Settings
去年
Lupin Gains FDA Approvals for HIV, Cystic Fibrosis, and Heart Failure Generics
去年
ViiV Healthcare Presents Real-World Data on Long-Acting HIV Treatments at IAS 2025
去年
GSK's Portfolio Resilience: Cancer and HIV Gains Offset RSV Vaccine Decline
去年
Dovato Shows Comparable Efficacy to Three-Drug Regimen in Advanced HIV
去年
Dovato Demonstrates High Efficacy in Treatment-Naive Individuals with Advanced HIV
6个月前
ViiV's Dovato Shows Lower Steatotic Liver Disease Risk Compared to Biktarvy in HIV Patients
7个月前
ViiV Healthcare Advances Ultra Long-Acting HIV Pipeline with Third-Generation Integrase Inhibitor VH184 Data at CROI 2026
11个月前
Dovato Demonstrates Non-Inferior Efficacy to Biktarvy with Significantly Less Weight Gain in 96-Week HIV Treatment Study
去年
Gilead's HIV Prevention Drug Yeztugo Exceeds Launch Expectations, Projected to Reach $5 Billion by 2031
第 1 页,共 4 页
上一页
下一页